Cargando…
Niclosamide ethanolamine ameliorates diabetes-related muscle wasting by inhibiting autophagy
BACKGROUND: Diabetes-related muscle wasting is one of the devastating complications of diabetes, which is associated with muscle autophagy due to insulin-mediated glucose starvation. However, treatment for diabetes-related muscle wasting is limited. Our previous study already found that niclosamide...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188694/ https://www.ncbi.nlm.nih.gov/pubmed/34107998 http://dx.doi.org/10.1186/s13395-021-00272-7 |
_version_ | 1783705376478199808 |
---|---|
author | Cai, Yuchun Zhan, Hongyue Weng, Wenci Wang, Yao Han, Pengxun Yu, Xuewen Shao, Mumin Sun, Huili |
author_facet | Cai, Yuchun Zhan, Hongyue Weng, Wenci Wang, Yao Han, Pengxun Yu, Xuewen Shao, Mumin Sun, Huili |
author_sort | Cai, Yuchun |
collection | PubMed |
description | BACKGROUND: Diabetes-related muscle wasting is one of the devastating complications of diabetes, which is associated with muscle autophagy due to insulin-mediated glucose starvation. However, treatment for diabetes-related muscle wasting is limited. Our previous study already found that niclosamide ethanolamine salt has the therapeutic effects on insulin deficiency of type 1 diabetes mice and muscle wasting induced by doxorubicin. Therefore, we aim to investigate the therapeutic effects of niclosamide ethanolamine salt on diabetes-induced muscle wasting and to explore whether the mechanism is associated with muscle autophagy. METHODS: Type 1 diabetes mice were induced by intraperitoneal injection of streptozotocin, then were fed with regular diet supplemented with 10 g/kg niclosamide ethanolamine salt. The whole experiment lasted for 8 weeks. At the end of the study, grip strength, weights of tibialis anterior, gastrocnemius, soleus, and extensor digitorum longus muscle were measured. Tibialis anterior muscles stained with PAS were used for evaluating the fiber cross sectional area. Immunofluorescence analysis of myosin heavy chain expression in extensor digitorum longus and soleus muscle was used for determining the composition of the muscle fiber type. Electronic microscopy was applied to observe the autophagy in the atrophied muscle. Serum insulin levels and fasting blood glucose were also measured. Tissues of gastrocnemius muscle were used for detecting the expression of the proteins related to autophagy. RESULTS: In this study, we found that niclosamide ethanolamine salt could ameliorate muscle atrophy in the type 1 diabetes mice as well, such as enhancing the declined grip strength, improving limb weight and increasing the numbers of glycolytic muscle fiber. Electron microscopy also confirmed that there did exist abundant autophagic vacuoles in the atrophied muscle of the type 1 diabetes mice. Specifically, niclosamide ethanolamine salt could reduce the over expression of autophagy-related proteins, including p-AMPK (Thr172), FoxO3a, p-ULK1 (Ser555), LC3B II, and p-p38 in gastrocnemius muscle of the type 1 diabetes mice. CONCLUSION: Niclosamide ethanolamine salt could ameliorate muscle wasting. The mechanisms underlying might be associated with inhibition of muscle autophagy. |
format | Online Article Text |
id | pubmed-8188694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81886942021-06-10 Niclosamide ethanolamine ameliorates diabetes-related muscle wasting by inhibiting autophagy Cai, Yuchun Zhan, Hongyue Weng, Wenci Wang, Yao Han, Pengxun Yu, Xuewen Shao, Mumin Sun, Huili Skelet Muscle Research BACKGROUND: Diabetes-related muscle wasting is one of the devastating complications of diabetes, which is associated with muscle autophagy due to insulin-mediated glucose starvation. However, treatment for diabetes-related muscle wasting is limited. Our previous study already found that niclosamide ethanolamine salt has the therapeutic effects on insulin deficiency of type 1 diabetes mice and muscle wasting induced by doxorubicin. Therefore, we aim to investigate the therapeutic effects of niclosamide ethanolamine salt on diabetes-induced muscle wasting and to explore whether the mechanism is associated with muscle autophagy. METHODS: Type 1 diabetes mice were induced by intraperitoneal injection of streptozotocin, then were fed with regular diet supplemented with 10 g/kg niclosamide ethanolamine salt. The whole experiment lasted for 8 weeks. At the end of the study, grip strength, weights of tibialis anterior, gastrocnemius, soleus, and extensor digitorum longus muscle were measured. Tibialis anterior muscles stained with PAS were used for evaluating the fiber cross sectional area. Immunofluorescence analysis of myosin heavy chain expression in extensor digitorum longus and soleus muscle was used for determining the composition of the muscle fiber type. Electronic microscopy was applied to observe the autophagy in the atrophied muscle. Serum insulin levels and fasting blood glucose were also measured. Tissues of gastrocnemius muscle were used for detecting the expression of the proteins related to autophagy. RESULTS: In this study, we found that niclosamide ethanolamine salt could ameliorate muscle atrophy in the type 1 diabetes mice as well, such as enhancing the declined grip strength, improving limb weight and increasing the numbers of glycolytic muscle fiber. Electron microscopy also confirmed that there did exist abundant autophagic vacuoles in the atrophied muscle of the type 1 diabetes mice. Specifically, niclosamide ethanolamine salt could reduce the over expression of autophagy-related proteins, including p-AMPK (Thr172), FoxO3a, p-ULK1 (Ser555), LC3B II, and p-p38 in gastrocnemius muscle of the type 1 diabetes mice. CONCLUSION: Niclosamide ethanolamine salt could ameliorate muscle wasting. The mechanisms underlying might be associated with inhibition of muscle autophagy. BioMed Central 2021-06-09 /pmc/articles/PMC8188694/ /pubmed/34107998 http://dx.doi.org/10.1186/s13395-021-00272-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Cai, Yuchun Zhan, Hongyue Weng, Wenci Wang, Yao Han, Pengxun Yu, Xuewen Shao, Mumin Sun, Huili Niclosamide ethanolamine ameliorates diabetes-related muscle wasting by inhibiting autophagy |
title | Niclosamide ethanolamine ameliorates diabetes-related muscle wasting by inhibiting autophagy |
title_full | Niclosamide ethanolamine ameliorates diabetes-related muscle wasting by inhibiting autophagy |
title_fullStr | Niclosamide ethanolamine ameliorates diabetes-related muscle wasting by inhibiting autophagy |
title_full_unstemmed | Niclosamide ethanolamine ameliorates diabetes-related muscle wasting by inhibiting autophagy |
title_short | Niclosamide ethanolamine ameliorates diabetes-related muscle wasting by inhibiting autophagy |
title_sort | niclosamide ethanolamine ameliorates diabetes-related muscle wasting by inhibiting autophagy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188694/ https://www.ncbi.nlm.nih.gov/pubmed/34107998 http://dx.doi.org/10.1186/s13395-021-00272-7 |
work_keys_str_mv | AT caiyuchun niclosamideethanolamineamelioratesdiabetesrelatedmusclewastingbyinhibitingautophagy AT zhanhongyue niclosamideethanolamineamelioratesdiabetesrelatedmusclewastingbyinhibitingautophagy AT wengwenci niclosamideethanolamineamelioratesdiabetesrelatedmusclewastingbyinhibitingautophagy AT wangyao niclosamideethanolamineamelioratesdiabetesrelatedmusclewastingbyinhibitingautophagy AT hanpengxun niclosamideethanolamineamelioratesdiabetesrelatedmusclewastingbyinhibitingautophagy AT yuxuewen niclosamideethanolamineamelioratesdiabetesrelatedmusclewastingbyinhibitingautophagy AT shaomumin niclosamideethanolamineamelioratesdiabetesrelatedmusclewastingbyinhibitingautophagy AT sunhuili niclosamideethanolamineamelioratesdiabetesrelatedmusclewastingbyinhibitingautophagy |